Postpartum Adherence Clubs to Enhance Support: the PACER Study
NCT02417675 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 258
Last updated 2018-02-13
Summary
The Western Cape province of South Africa (SA) is changing the way it treats pregnant women with HIV. Now, all HIV-infected pregnant women, regardless of how sick or healthy they are, will receive antiretroviral treatment (ART) for life ("Option B+"). However, there are few well-developed models of service delivery to support this change to "Option B+" in the Western Cape and many parts of the continent.
The parent study -- Strategies to Optimize ART Services for Maternal \& Child Health (MCH-ART)-- is testing two clinic-based models of service delivery for Option B+ . To complement MCH-ART, this study, PACER, will test whether community-based Adherence Clubs are an effective model for keeping breastfeeding women in HIV care after pregnancy. These clubs have been used to free up space at ART clinics by moving stable HIV+ patients to community-based services, but they have not been studied as an effective strategy among breastfeeding women after delivery. PACER seeks to address this gap.
Conditions
Interventions
- OTHER
-
Community-based Adherence Clubs
Women in the AC arm are prescribed 2 months of their current ART medication (compared to 1 month in the SOC) and will be advised to go to the AC office immediately, where they will be scheduled for their first session. Women will attend AC meetings every two months. At these meetings, women will receive a 2 month supply of medication, health education and peer-support. A trained Community Health Worker (CHW) will also collect blood samples, weight, and current signs/symptoms from women. Each participant has 5 working days after their AC session to come and collect her medication. Those who have defaulted will be followed up by the CHW via phone calls and, possibly, home visits. If reached, women will be told to return immediately to the main ART facility for receipt of ART care.
- OTHER
-
Standard of Care for Mothers
Women will be referred immediately from the maternity ART clinic to their nearest adult ART clinic at their first postpartum clinic visit. At referral, they receive an initial 1-month supply of their current ART medication. At the first appointment after transfer into the general ART service, patients undergo clinical history and examination by a doctor or clinical nurse practitioner. Laboratory investigations are ordered according to standard protocols or based on clinician discretion. For the 1st 4 months in the new service, stable patients are dispensed 1 month of ART; subsequent visits are 2-monthly for medication refill, with clinician review 6-monthly; patients with particular clinical or psychosocial concerns may be reviewed more regularly, or referred to higher levels of care.
- OTHER
-
Standard of Care for Infants
All infants will receive care at their nearest primary care clinic. Following national protocols, all HIV-infected mothers are issued a 6-week supply of nevirapine syrup after delivery and counselled on daily nevirapine prophylaxis. Infant follow-up takes place within 1 week postpartum with the mother (at the MOU) and then at 6 weeks postpartum (at the nearest primary care clinic) when HIV PCR testing of the infant is carried out. Following national protocols, infants who are breastfed beyond 6 weeks receive HIV PCR testing 2-4 weeks after the cessation of breastfeeding, again conducted at the nearest City of Cape Town primary care clinic.
Sponsors & Collaborators
-
National Institutes of Health (NIH)
collaborator NIH -
Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)
collaborator NIH - lead OTHER
Principal Investigators
-
Elaine J Abrams, MD · ICAP at Columbia University
-
Landon Myer, MD · University of Cape Town
Study Design
- Allocation
- RANDOMIZED
- Purpose
- SUPPORTIVE_CARE
- Masking
- NONE
- Model
- PARALLEL
Eligibility
- Min Age
- 18 Years
- Sex
- FEMALE
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2015-02-28
- Primary Completion
- 2016-10-31
- Completion
- 2016-10-31
Countries
- South Africa
Study Locations
More Related Trials
-
Effects of Facility-based Mother Support Groups on Prevention of mother-to Child Transmission Outcomes in Zimbabwe
NCT02216734 ·Status: UNKNOWN ·Phase: NA
-
Pediatric Enhanced Surveillance Study
NCT02043769 ·Status: COMPLETED
-
Positive Attitudes Concerning Infant Feeding- a Questionnaire for Women Living With HIV
NCT03294499 ·Status: COMPLETED
-
ART Readiness in HIV-infected Pregnant Women
NCT02459678 ·Status: COMPLETED ·Phase: NA
-
Evaluation of Pre-exposure Prophylaxis Cascade in Pregnant and Breastfeeding Women in Cape Town (Formative Study)
NCT03826199 ·Status: COMPLETED ·Phase: PHASE4
-
Evaluating Strategies to Reduce Mother-to-Child Transmission of HIV Infection in Resource-Limited Countries
NCT01061151 ·Status: COMPLETED ·Phase: PHASE3
-
An Integrated Strategy to Support Antiretroviral Therapy and Pre-exposure Prophylaxis Adherence for HIV Prevention in Pregnant and Breastfeeding Women
NCT04330989 ·Status: COMPLETED ·Phase: NA
-
Strategies to Optimize Antiretroviral Therapy Services for Maternal & Child Health: the MCH-ART Study
NCT01933477 ·Status: COMPLETED ·Phase: NA
-
Early Infant HIV Treatment in Botswana
NCT02369406 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE2/PHASE3
-
Clinical Study of an Aluvia-based HAART Regimen for Prevention of Mother-to-child HIV Transmission in Africa
NCT01088516 ·Status: COMPLETED ·Phase: PHASE4
-
Swaziland Safe Generations
NCT01891799 ·Status: COMPLETED
-
Early ART Initiation Among HIV-positive Pregnant Women in Central Mozambique
NCT02371265 ·Status: COMPLETED ·Phase: NA
-
Long Term Outcomes of Therapy in Women Initiated on Lifelong ART Because of Pregnancy in DR Congo
NCT03048669 ·Status: COMPLETED ·Phase: NA
-
CareConekta: A Pilot Study of a Smartphone App in South Africa
NCT03157908 ·Status: COMPLETED ·Phase: NA
-
Mother Infant Retention for Health: MIR4Health
NCT01962220 ·Status: COMPLETED ·Phase: NA
-
A Study to Collect Information About HIV-Positive Pregnant Women and Their Babies
NCT00000910 ·Status: COMPLETED
-
Latency and Early Neonatal Provision of Antiretroviral Drugs Clinical Trial
NCT02431975 ·Status: COMPLETED ·Phase: PHASE4
-
Vertical Transmission Study
NCT01948557 ·Status: COMPLETED ·Phase: NA
-
Extended Infant Post-exposure Prophylaxis With Antiretrovirals to Reduce Postnatal HIV Transmission
NCT00115648 ·Status: COMPLETED ·Phase: PHASE3
-
A Prospective, Observational Study of HIV-Infected Pregnant Women and Their Infants at Clinical Sites in Latin American and Caribbean Countries
NCT00341302 ·Status: COMPLETED
-
Evaluation of a Differentiated Point-of-care Active Case Finding & Management Model to Eliminate Mother-to-Child Transmission of HIV in Malawi
NCT06493357 ·Status: RECRUITING ·Phase: NA
-
Enhanced Mentor Mother Strategy for Pregnant and Postpartum Women Living With HIV
NCT06999928 ·Status: RECRUITING ·Phase: NA
-
Dolutegravir in Pregnant HIV Mothers and Their Neonates
NCT03249181 ·Status: COMPLETED ·Phase: PHASE3
-
IMPAACT P1074: Long-Term Outcomes in HIV-Infected Infants, Children, and Adolescents
NCT01061164 ·Status: COMPLETED
-
Using Nevirapine to Prevent Mother-to-Child HIV Transmission During Breastfeeding
NCT00074412 ·Status: COMPLETED ·Phase: PHASE3